NIHR, founded in the UK in 2006, is a corporate investor that focuses on funding startups in the medical device and biotechnology sectors. It typically invests in rounds with one participant and has been involved in less than two deals per year. NIHR has a higher rate of exit compared to other organizations and tends to invest in startups that are 6-10 years old. Some of its notable portfolio startups include Quanta.